BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 21126596)

  • 21. How I treat bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
    Williams KM
    Blood; 2017 Jan; 129(4):448-455. PubMed ID: 27856461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive value of bronchiolitis obliterans syndrome stage 0p in chronic graft-versus-host disease of the lung.
    Abedin S; Yanik GA; Braun T; Pawarode A; Magenau J; Goldstein SC; Levine JE; Kitko CL; Couriel DR
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1127-31. PubMed ID: 25687798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First-Onset Herpesviral Infection and Lung Injury in Allogeneic Hematopoietic Cell Transplantation.
    Zhou X; O'Dwyer DN; Xia M; Miller HK; Chan PR; Trulik K; Chadwick MM; Hoffman TC; Bulte C; Sekerak K; Wilke CA; Patel SJ; Yokoyama WM; Murray S; Yanik GA; Moore BB
    Am J Respir Crit Care Med; 2019 Jul; 200(1):63-74. PubMed ID: 30742492
    [No Abstract]   [Full Text] [Related]  

  • 24. Early outcomes of lung transplantation for bronchiolitis obliterans syndrome after allogeneic haematopoietic stem cell transplantation: a single-centre experience.
    Jung HS; Lee JG; Yu WS; Lee CY; Haam SJ; Paik HC
    Interact Cardiovasc Thorac Surg; 2016 Dec; 23(6):914-918. PubMed ID: 27481680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical analysis of bronchiolitis obliterans syndrome after haplo- hematopoietic stem cell transplantation].
    Zhuang J; Gu B; Ke P; Liu YJ; Wu XJ; Xue SL; Hu XH; He XF; Ma X; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2019 May; 40(5):404-410. PubMed ID: 31207706
    [No Abstract]   [Full Text] [Related]  

  • 26. Lung transplantation for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: a single-center experience.
    Vogl UM; Nagayama K; Bojic M; Hoda MA; Klepetko W; Jaksch P; Dekan S; Siersch V; Mitterbauer M; Schellongowski P; Greinix HT; Petkov V; Schulenburg A; Kalhs P; Rabitsch W
    Transplantation; 2013 Feb; 95(4):623-8. PubMed ID: 23274967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donor lymphocyte infusion may reduce the incidence of bronchiolitis obliterans after allogeneic stem cell transplantation.
    Forslöw U; Mattsson J; Gustafsson T; Remberger M
    Biol Blood Marrow Transplant; 2011 Aug; 17(8):1214-21. PubMed ID: 21193056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reliability of diagnostic criteria for bronchiolitis obliterans syndrome after lung transplantation: a survey.
    Kapila A; Baz MA; Valentine VG; Bhorade SM;
    J Heart Lung Transplant; 2015 Jan; 34(1):65-74. PubMed ID: 25447585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Lung Function on Bronchiolitis Obliterans Syndrome and Outcome after Allogeneic Hematopoietic Cell Transplantation with Reduced-Intensity Conditioning.
    Duque-Afonso J; Ihorst G; Waterhouse M; Zeiser R; Wäsch R; Bertz H; Müller-Quernheim J; Finke J; Marks R; Prasse A
    Biol Blood Marrow Transplant; 2018 Nov; 24(11):2277-2284. PubMed ID: 29964193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation.
    Williams KM; Cheng GS; Pusic I; Jagasia M; Burns L; Ho VT; Pidala J; Palmer J; Johnston L; Mayer S; Chien JW; Jacobsohn DA; Pavletic SZ; Martin PJ; Storer BE; Inamoto Y; Chai X; Flowers MED; Lee SJ
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):710-716. PubMed ID: 26475726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inert Gas Washout in Bronchiolitis Obliterans Following Hematopoietic Cell Transplantation.
    Nyilas S; Baumeler L; Tamm M; Halter JP; Savic S; Korten I; Meyer A; Singer F; Passweg JR; Latzin P; Stolz D
    Chest; 2018 Jul; 154(1):157-168. PubMed ID: 29275133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between chronic bacterial airway infection and prognosis of bronchiolitis obliterans syndrome after hematopoietic cell transplantation.
    Yomota M; Yanagawa N; Sakai F; Yamada Y; Sekiya N; Ohashi K; Okamura T
    Medicine (Baltimore); 2019 Jan; 98(1):e13951. PubMed ID: 30608429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term pulmonary function testing in pediatric bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
    Walther S; Rettinger E; Maurer HM; Pommerening H; Jarisch A; Sörensen J; Schubert R; Berres M; Bader P; Zielen S; Jerkic SP
    Pediatr Pulmonol; 2020 Jul; 55(7):1725-1735. PubMed ID: 32369682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic role of FEV1 for survival in bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation.
    Ahn JH; Jo KW; Song JW; Shim TS; Lee SW; Lee JS; Kim DY; Lee JH; Lee JH; Choi Y; Lee KH
    Clin Transplant; 2015 Dec; 29(12):1133-9. PubMed ID: 26383085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preventing and managing bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation.
    Chien JW
    Expert Rev Respir Med; 2011 Feb; 5(1):127-35. PubMed ID: 21348593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for bronchiolitis obliterans syndrome in allogeneic hematopoietic stem cell transplantation.
    Mo XD; Xu LP; Liu DH; Zhang XH; Chen H; Chen YH; Han W; Wang Y; Wang FR; Wang JZ; Liu KY; Huang XJ
    Chin Med J (Engl); 2013 Jul; 126(13):2489-94. PubMed ID: 23823823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
    Barba P; Piñana JL; Valcárcel D; Querol L; Martino R; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1439-46. PubMed ID: 19822304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Late pulmonary complications after allogeneic hematopoietic stem cell transplantation: diagnosis, monitoring, prevention, and treatment.
    Bacigalupo A; Chien J; Barisione G; Pavletic S
    Semin Hematol; 2012 Jan; 49(1):15-24. PubMed ID: 22221781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
    Galbán CJ; Boes JL; Bule M; Kitko CL; Couriel DR; Johnson TD; Lama V; Telenga ED; van den Berge M; Rehemtulla A; Kazerooni EA; Ponkowski MJ; Ross BD; Yanik GA
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1592-8. PubMed ID: 24954547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening with spirometry is a useful predictor of later development of noninfectious pulmonary syndromes in patients undergoing allogeneic stem cell transplantation.
    Thompson PA; Lim A; Panek-Hudson Y; Tacey M; Hijazi R; Ng AP; Szer J; Ritchie D; Bajel A
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):781-6. PubMed ID: 24548876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.